Skip to content

Zealand, Roche Start Petrelintide Phase 3 as 100% Pharma Tariffs Begin — September 29, 2026

September 29, 2026 · 9 min

Show notes

Zealand Pharma and Roche have launched a roughly 7,000-person Phase 3 program for once-weekly petrelintide in obesity. Meanwhile, a baseline 100 percent Section 232 tariff on imported patented medicines and ingredients takes effect and EASD convenes in Milan.

In this episode
  1. Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma - Medical Update Online — Medical Update Online

    Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma - Medical Update Online # Global Registrational Phase 3 ZUPREME Program Evaluating Petrelintide in Overweight or Obesity Initiated – Zealand Pharma Written by Charlie King | 27 Sep 2026 | Diabetes & Endocrinology Zealand Pharma A/S announces the initiation of the global…

  2. Navigating Pharma’s Forced Supply Chain Revolution - Chemistry Today — Chemistry Today

    Navigating Pharma’s Forced Supply Chain Revolution - Chemistry Today # Navigating Pharma’s Forced Supply Chain Revolution by [email protected] 28 September 2026 M. Klote 28 September 2026 Molly Klote, MD President and CEO, Klote Medical Research Advisors, LLC, Washington, DC, United States Former Director, Office for Human Research Protections, US Department of Health and Human…

  3. EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity - Dagensdiabetes — Dagens Diabetes

    EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity - Dagensdiabetes Senaste Nr DiabetologNytt i PDF ## EASD 2026 to Feature New Diabetes Approaches in T1DM, T2DM, obesity Key Points • This year’s European Association for the Study of Diabetes (EASD) 2026 Annual Meeting in Milan, Italy, (from September 28 to October 2) will feature new data on first-line treatment approaches…

  4. Republicans and Democrats Find a Unifying Target: Pharmacy Benefit Managers — KFF Health News

    Amye Joseph says America’s political polarization has made it an “interesting time” in her Tennessee household. She and her husband, Charlie, have been married 35 years. She’s a Republican. He’s a Democrat. But their shared disenchantment with profit-driven healthcare has provided a unifying target: pharmacy benefit managers, known as PBMs. The Josephs’ frustration is focused on CVS Health. The…

  5. Oral solid dose at a turning point: Scaling for the next generation of therapies - Pharmaceutical Technology — Pharmaceutical Technology

    Oral solid dose at a turning point: Scaling for the next generation of therapies - Pharmaceutical Technology # Oral solid dose at a turning point: Scaling for the next generation of therapies From patient-centric designs and sustainable changes to component shortages, anti-counterfeiting, and low-volume production, sponsors of oral solid dose pharmaceuticals and their CDMOs are navigating a…

Daily TopFive for GLP-1 Daily. Links above go to the original articles. Follow and rate GLP-1 Daily on Apple Podcasts. Feedback? Email [email protected].

All episodes of GLP-1 Daily: Ozempic & Wegovy News

Settings

Display

Language

Decides which stations you see first on the home page.

History

Recently played stations and episodes and your latest searches are only stored in this browser.

Notifications

A short notice when a podcast you follow has a new episode. Turn off single podcasts with the bell on their page.

Account

Save favorites – in the app and on the website.

Keyboard shortcuts

/
Open search
Space
Play or pause
← →
In the player: back 15 s, forward 30 s (episodes) · in a row: next tile
↑ ↓
In a row: target within the tile
Home / End
In a row: first or last tile
Esc
Close window or menu
?
This overview
Now playing

Go to station page

Play next

    Add episodes with “Play next” – they play after the current episode.